Amlodipine Besylate; Olmesartan Medoxomil is Used for managing high blood pressure. It was first introduced by Cosette Pharmaceuticals Inc in its drug Azor on Sep 26, 2007. 15 different companies have introduced drugs containing Amlodipine Besylate; Olmesartan Medoxomil.
Amlodipine Besylate; Olmesartan Medoxomil Patents
Given below is the list of patents protecting Amlodipine Besylate; Olmesartan Medoxomil, along
with the drug name that holds that patent and the company name owning that
drug.
Amlodipine Besylate; Olmesartan Medoxomil's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Amlodipine Besylate; Olmesartan Medoxomil Generic API Manufacturers
Several generic applications have been filed for Amlodipine Besylate; Olmesartan Medoxomil. The first generic version for Amlodipine Besylate; Olmesartan Medoxomil was by Teva Pharmaceuticals Usa and was approved on Oct 26, 2016. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Feb 14, 2025.
Given below is the list of companies who have filed for
Amlodipine Besylate; Olmesartan Medoxomil generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE INC
Accord Healthcare Inc Usa has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Accord Hlthcare Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
Aug 30, 2018
EQ 5MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
Aug 30, 2018
EQ 10MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
Aug 30, 2018
EQ 5MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
Aug 30, 2018
2. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Ajanta Pharma Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE; 40MG
tablet
Prescription
ORAL
AB
Oct 28, 2016
EQ 5MG BASE; 20MG
tablet
Prescription
ORAL
AB
Oct 28, 2016
EQ 5MG BASE; 40MG
tablet
Prescription
ORAL
AB
Oct 28, 2016
EQ 10MG BASE; 20MG
tablet
Prescription
ORAL
AB
Oct 28, 2016
Manufacturing Plant Locations
New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
Country
City
Firm Name
India
Aurangabad
Ajanta Pharma Ltd.
3. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Alembic.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE; 20MG
tablet
Prescription
ORAL
AB
Jul 17, 2017
EQ 10MG BASE; 40MG
tablet
Prescription
ORAL
AB
Jul 17, 2017
EQ 10MG BASE; 20MG
tablet
Prescription
ORAL
AB
Jul 17, 2017
EQ 5MG BASE; 40MG
tablet
Prescription
ORAL
AB
Jul 17, 2017
Manufacturing Plant Locations
New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Alkem Labs Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE; 20MG
tablet
Prescription
ORAL
AB
Aug 14, 2017
EQ 5MG BASE; 40MG
tablet
Prescription
ORAL
AB
Aug 14, 2017
EQ 10MG BASE; 20MG
tablet
Prescription
ORAL
AB
Aug 14, 2017
EQ 10MG BASE; 40MG
tablet
Prescription
ORAL
AB
Aug 14, 2017
5. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Aurobindo Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE; 20MG
tablet
Prescription
ORAL
AB
May 15, 2017
EQ 5MG BASE; 40MG
tablet
Prescription
ORAL
AB
May 15, 2017
EQ 10MG BASE; 20MG
tablet
Prescription
ORAL
AB
May 15, 2017
EQ 10MG BASE; 40MG
tablet
Prescription
ORAL
AB
May 15, 2017
Manufacturing Plant Locations
New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country
City
Firm Name
India
Sangareddy
Aurobindo Pharma Limited
Polepally, Mahaboob Nagar
Aurobindo Pharma Limited
Medchal
Aurobindo Pharma Ltd
Bachupally
Aurobindo Pharma Limited
United States
East Windsor
Aurobindo Pharma USA Inc
6. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Glenmark Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
Jul 5, 2017
EQ 5MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
Jul 5, 2017
EQ 10MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
Jul 5, 2017
EQ 10MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
Jul 5, 2017
7. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Hetero Labs Ltd V.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE; 40MG
tablet
Prescription
ORAL
AB
Feb 14, 2025
EQ 10MG BASE; 20MG
tablet
Prescription
ORAL
AB
Feb 14, 2025
EQ 5MG BASE; 40MG
tablet
Prescription
ORAL
AB
Feb 14, 2025
EQ 5MG BASE; 20MG
tablet
Prescription
ORAL
AB
Feb 14, 2025
8. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Jubilant Generics.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
May 15, 2017
EQ 10MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
May 15, 2017
EQ 10MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
May 15, 2017
EQ 5MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
May 15, 2017
Manufacturing Plant Locations
New
Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.
Country
City
Firm Name
India
Roorkee
Jubilant Generics Limited
9. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Macleods Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE; 40MG
tablet
Prescription
ORAL
AB
Oct 26, 2016
EQ 5MG BASE; 40MG
tablet
Prescription
ORAL
AB
Oct 26, 2016
EQ 5MG BASE; 20MG
tablet
Prescription
ORAL
AB
Oct 26, 2016
EQ 10MG BASE; 20MG
tablet
Prescription
ORAL
AB
Oct 26, 2016
10. MICRO LABS
Micro Labs Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Micro Labs.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE; 20MG
tablet
Prescription
ORAL
AB
Nov 2, 2017
EQ 10MG BASE; 40MG
tablet
Prescription
ORAL
AB
Nov 2, 2017
EQ 10MG BASE; 20MG
tablet
Prescription
ORAL
AB
Nov 2, 2017
EQ 5MG BASE; 40MG
tablet
Prescription
ORAL
AB
Nov 2, 2017
Manufacturing Plant Locations
New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
Country
City
Firm Name
India
Bangalore
Micro Labs Limited
Bengaluru
Micro Labs Limited, Central Analytical Laboratory
Verna
Micro Labs Limited
Bengaluru
Micro Labs Limited
11. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Sciegen Pharms Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE; 20MG
tablet
Prescription
ORAL
AB
Dec 3, 2018
EQ 5MG BASE; 40MG
tablet
Prescription
ORAL
AB
Dec 3, 2018
EQ 10MG BASE; 20MG
tablet
Prescription
ORAL
AB
Dec 3, 2018
EQ 10MG BASE; 40MG
tablet
Prescription
ORAL
AB
Dec 3, 2018
12. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Teva Pharms Usa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
Oct 26, 2016
EQ 5MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
Oct 26, 2016
EQ 5MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
Oct 26, 2016
EQ 10MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
Oct 26, 2016
13. TORRENT
Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Torrent.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 5MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
Nov 25, 2016
EQ 10MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
Nov 25, 2016
EQ 10MG BASE; 20MG
tablet
Discontinued
ORAL
N/A
Nov 25, 2016
EQ 5MG BASE; 40MG
tablet
Discontinued
ORAL
N/A
Nov 25, 2016
Manufacturing Plant Locations
New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
Country
City
Firm Name
India
Gandhi Nagar
Torrent Pharmaceuticals Limited
Pithampur
Torrent Pharmaceuticals Limited
Indrad
Torrent Pharmaceuticals Limited
Bharuch
Torrent Pharmaceuticals Limited
Thanam
Torrent Pharmaceuticals Limited
United States
Basking Ridge
Torrent Pharma Inc.
Kalamazoo
Torrent Pharma Inc.
14. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the
details of the strengths of this generic introduced by
Zydus Pharms.
